This article is more than 5 years old. Information may no longer be current.

Revenue continues to rise at Carl Zeiss Meditec

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

In the first 9 months of its fiscal year, revenue at Carl Zeiss Meditec rose to €630.8 million, a 13.6% increase compared with a year ago, according to a news release. The company expects full-year revenue of €830 million to €860 million, meeting its forecast.

“In spite of an increasingly difficult situation in the global economy, we achieved a solid result, with double-digit revenue growth, and stick firmly to our revenue forecast for the year as a whole,” Ludwin Monz, PhD, MBA, president and CEO of Carl Zeiss Meditec, said in the release.

Growth was led by the microsurgery unit, which had a 21.6% increase in revenue over the same period last year. The surgical ophthalmology unit had a 13.3% increase in revenue, while the ophthalmic systems unit had a 6.1% increase, according to the release.

The Americas region had a 14.1% gain in revenue over the same period last year, the release said. The Asia-Pacific region increased by 13.7%, and the Europe-Middle East-Africa region rose by 12.9%.